National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 66771-66772 [2010-27319]

Download as PDF Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Ste 703, Rm 7072, Bethesda, MD 20892–8329, 301–594–1408, Stoicaa2@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 25, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. The Lead in Water Panel: The State of the Science panel discussions. Opportunities will be provided during the meeting for oral comments. Agenda items are subject to change as priorities dictate. For Further Information Contact: Claudine Johnson, Program Operation Assistant, Lead Poisoning Prevention Branch, Division of Environmental Emergency Health Services, NCEH, CDC, 4770 Buford Highway, NE., Mailstop F–60, Atlanta, GA 30341, telephone 770 488–3629, fax 770 488–3635. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: October 22, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–27365 Filed 10–28–10; 8:45 am] [FR Doc. 2010–27410 Filed 10–28–10; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) WReier-Aviles on DSKGBLS3C1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC, National Center for Environmental Health (NCEH) announces the following committee meeting: Dates and Times: November 16, 2010, 8:30 a.m.–5 p.m. November 17, 2010, 8:30 a.m.–5 p.m. November 18, 2010, 8:30 a.m.–12 p.m. Place: The Westin Atlanta North at Perimeter, Seven Concourse Parkway, Atlanta, Georgia 30328, (770) 395–3900. Status: This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: The Committee provides advice and guidance to the Secretary; the Assistant Secretary for Health; and the Director, CDC, regarding new scientific knowledge and technological developments and their practical implications for childhood lead poisoning prevention efforts. The committee also reviews and reports regularly on childhood lead poisoning prevention practices and recommends improvements in national childhood lead poisoning prevention efforts. Matters to be Discussed: The agenda will include discussions on: (1) The New York State Childhood Lead Poisoning Program; (2) the Educational Intervention Workgroup; (3) the Laboratory Workgroup; (4) the Consumer Product Workgroup; (5) the National Health and Nutrition Examination Survey (NHANES) Blood Lead Estimate; (6) the Blood Lead Level of ‘‘Concern’’; (7) Federal agency updates; (8) discussion of CDC recommendations for lead in water; and (9) VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Glial Lineage in Disease Progression. Date: November 22, 2010. Time: 12 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852. Contact Person: Norman Chang, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–496–1485, changn@mail.nih.gov. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 66771 (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 22, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–27331 Filed 10–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, December 6, 2010, 8 a.m. to December 6, 2010, 5 p.m., Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852 which was published in the Federal Register on October 15, 2010, 75FR63494. This notice is amending the start and end times of the meeting from 8 a.m.– 5 p.m. to 8:30 a.m.–6 p.m. The meeting is closed to the public. Dated: October 22, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–27328 Filed 10–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\29OCN1.SGM 29OCN1 66772 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices WReier-Aviles on DSKGBLS3C1PROD with NOTICES Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases (CADET I). Date: November 18–19, 2010. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Keary A Cope, PhD, Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892–7924, (301) 435–2222, copeka@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Common Pathogenetic Mechanisms of Lung Cancer and COPD. Date: November 19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Robert T. Su, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892–7924, 301–435–0297, sur@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Next Generation Genetic Association Studies. Date: November 19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications, Place: Westin BWI (Baltimore), 1100 Old Elkridge Landing Road, Baltimore, MD 21090. Contact Person: David A Wilson, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892–7924, 301–435–0299, wilsonda2@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 22, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–27319 Filed 10–28–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Dated: October 22, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–27462 Filed 10–28–10; 8:45 am] Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Date: 10:30 a.m.–12 p.m., November 15, 2010. Place: Teleconference. Status: Open to the public, the toll free dial in number is 1(800)369–1755 with a pass code of 8481618. Purpose: The BSC, OID, shall advise the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, concerning strategies, goals, and priorities for the programs and research within the national centers and monitor the overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: The meeting will involve the presentation of a draft document being developed to advance CDC’s infectious disease priorities. A subsequent meeting to solicit further discussion and input on the document from the board is currently scheduled for December 6, 2010 and will be announced at a future date. Requests for a copy of the draft document may be sent to ddidinput@cdc.gov prior to the teleconference. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, CDC, OID, 1600 Clifton Road, NE., Mailstop D–10, Atlanta, Georgia 30333, telephone (404) 639– 4461. The Director, Management and Analysis Services Office, has been delegated the authority to sign the Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the Sleep Disorders Research Advisory Board. The meetings will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meetings Name of Committee: Sleep Disorders Research Advisory Board. Date: November 12, 2010. Time: 3 p.m. to 5 p.m. Agenda: To discuss sleep research programs and sleep research strategic planning. Public meeting observers should call 1–800–779–2608 to access the teleconference and the observer passcode is 7989226. Public meeting observers should send comments or questions for this meeting to the National Center on Sleep Disorders Research by e-mail mt2d@nih.gov or fax 301– 480–3557. Place: National Institutes of Health, 6701 Rockledge Drive, Suite 10170, Bethesda, MD 20892 (Telephone Conference Call.) Contact Person: Michael J Twery, PhD, Director, National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Suite 10038, Bethesda, MD 20892–7952, 301– 435–0199, twerym@nhlbi.nih.gov. Name of Committee: Sleep Disorders Research Advisory Board. Date: December 10, 2010. Time: 8:30 a.m. to 4 p.m. Agenda: To discuss sleep research programs and sleep research strategic planning. Place: National Institutes of Health, Building 31, 31 Center Drive, C–Wing, Conference Room 6, Bethesda, MD 20892. Contact Person: Michael J Twery, PhD, Director, National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Suite 10038, Bethesda, MD 20892–7952,301– 435–0199, twerym@nhlbi.nih.gov. Any interested person may file written comments with the committee by E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Pages 66771-66772]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27319]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 66772]]


    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Centers for Advanced Diagnostics and 
Experimental Therapeutics in Lung Diseases (CADET I).
    Date: November 18-19, 2010.
    Time: 6 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Keary A Cope, PhD, Scientific Review Officer, 
Office of Scientific Review, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 
(301) 435-2222, copeka@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Common Pathogenetic Mechanisms of Lung 
Cancer and COPD.
    Date: November 19, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Robert T. Su, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7202, Bethesda, MD 20892-7924, 301-435-0297, 
sur@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Next Generation Genetic Association Studies.
    Date: November 19, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications,
    Place: Westin BWI (Baltimore), 1100 Old Elkridge Landing Road, 
Baltimore, MD 21090.
    Contact Person: David A Wilson, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7204, Bethesda, MD 20892-7924, 301-435-0299, 
wilsonda2@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: October 22, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-27319 Filed 10-28-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.